Atlas Trials

Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia

Clinical trial NCT00409201 · UNKNOWN

Trial details

NCT number
NCT00409201
Sponsor
Abarbanel Mental Health Center
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.